Home > Newsletters > Drug Industry Daily > Pipeline Woes Strike Sanofi, Ipsen, Eisai: Nixed Applications, Clinical Holds and Trial Failures
Drug Industry Daily
July 11, 2012 | Vol. 11 No. 135
Pipeline Woes Strike Sanofi, Ipsen, Eisai: Nixed Applications, Clinical Holds and Trial Failures
Sanofi, Ipsen and Eisai all took pipeline hits this week, with late-stage setbacks including Sanofi’s withdrawal of marketing applications for a blood-clot drug, Ipsen’s clinical hold for an investigational hemophilia drug and Eisai’s failed breast cancer trial.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.